ArticlePDF Available

Phytotherapy and psoriasis: Complementary and alternative medications

Authors:

Abstract

Psoriasis comprises severe skin problems affects on quality of patient’s life. It affects 2% of the general population with age before 35 years old. Most potent and cheap psoriatic drugs are still largely unavailable. Recently, as aresult of the apparent side effects of chemical drugs, treatments of herbal origin gains the popularity among patients with skin disorders especially those for psoriasis. In this review, the uses of complementary and alternative medications of various topical herbal formulae with different potency against psoriasis was greatly assessed. Modified Psoriasis scoring systems were performed as evident of improvement when various topical herbal formula including traditional chinese medicine ingredients such as Camptotheca acuminate, Oleum horwathiensis, Capsaicin, furocoumarins, Curcumin, and Tars were used against psoriasis. Also, plant extracts of Aleo Vera, and green tea were reported in topical form for the treatment of psoriasis. Most studies indicated a variety of biological activities of used herbs depending on their chemical constituents. This versatile range of biological activities explaining,the apparent benefits of these herbs in monitoring of psoriasis.
Published by Baishideng Publishing Group Inc
World Journal of
Dermatology
World J Dermatol 2014 November 2; 3(4): 76-91
ISSN 2218-6190
(online)
76
Psoriasis: Biologic treatment and liver disease
Vilarrasa E, Puig L
86
Phytotherapy and psoriasis: Complementary and alternative medications
Gabr SA, Alghadir AH
Contents
IWJD
|
www.wjgnet.com November 2, 2014
|
Volume 3
|
Issue 4
|
W
J
D
World Journal of
Dermatology
Quarterly Volume 3 Number 4 November 2, 2014
REVIEW
MINIREVIEWS
Contents
World Journal of Dermatology
Volume 3 Number 4 November 2, 2014
EDITORS FOR
THIS ISSUE
Responsible Assistant Editor:
Xiang Li
Responsible Science Editor:
Xue-Mei Gong
Responsible Electronic Editor:
Su-Qing Liu Proong Editorial Ofce Director: Xiu-Xia Song
Proong Editor-in-Chief:
Lian-Sheng Ma
No. 62 Dongsihuan Zhonglu, Chaoyang District,
Beijing 100025, China
Telephone: +86-10-85381891
Fax: +86-10-85381893
E-mail: editorialofce@wjgnet.com
Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx
http://www.wjgnet.com
PUBLISHER
Baishideng Publishing Group Inc
8226 Regency Drive,
Pleasanton, CA 94588, USA
Telephone: +1-925-223-8242
Fax: +1-925-223-8243
E-mail: bpgofce@wjgnet.com
Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx
http://www.wjgnet.com
PUBLICATION DATE
November 2, 2014
COPYRIGHT
© 2014 Baishideng Publishing Group Inc. Articles pub-
lished by this Open-Access journal are distributed under
the terms of the Creative Commons Attribution Non-
commercial License, which permits use, distribution,
and reproduction in any medium, provided the original
work is properly cited, the use is non commercial and is
otherwise in compliance with the license.
SPECIAL STATEMENT
All articles published in journals owned by the Baishideng
Publishing Group (BPG) represent the views and
opinionsof their authors, and not the views, opinions
or policies of the BPG, except where otherwise ex-
plicitly indicated.
INSTRUCTIONS TO AUTHORS
Full instructions are available online at http://www.
wjgnet.com/2218-6190/g_info_20100722173304.htm.
ONLINE SUBMISSION
http://www.wjgnet.com/esps/
IIWJD
|
www.wjgnet.com
APPENDIX
ABOUT COVER
AIM AND SCOPE
FLYLEAF
November 2, 2014
|
Volume 3
|
Issue 4
|
NAME OF JOURNAL
World Journal of Dermatology
ISSN
ISSN 2218-6190 (online)
LAUNCH DATE
June 2, 2012
FREQUENCY
Quarterly
EDITOR-IN-CHIEF
Santosh K Katiyar, PhD, Professor,
Department of
Dermatology, University of Alabama at Birmingham,
Birmingham, AL 35294, United States
EDITING
Jin-Lei Wang, Director
Xiu-Xia Song, Vice Director
World Journal of Dermatology
Room 903, Building D, Ocean International Center,
I-V
Instructions to authors
Editorial Board Member of
World Journal of Dermatology
, Cheng Tan, MD,
PhD, Associate Professor, Department of Dermatology, First Affiliated Hospital
of Nanjing University of Traditional Chinese Medicine, 155, Hanzhong Road,
Nanjing 210029, JiangSu Province, China
World Journal of Dermatology
(
World J Dermatol
,
WJD
, online ISSN 2218-6190, DOI:
10.5314),
is a peer-reviewed open access (OA) academic journal that aims to guide clinical
practice and improve diagnostic and therapeutic skills of clinicians
.
WJD
is to report rapidly new theories, methods and techniques for prevention, diag-
nosis, treatment, rehabilitation and nursing in the eld of dermatology.
WJD
covers fungal
diseases, dermatitis and eczema, urticarial diseases, drug eruptions, pruritus, erythroderma
desquamativum, connective tissue diseases, bullous skin diseases, vascular skin diseases,
skin appendage diseases, pigmentary diseases, genetic diseases, nutritional and metabolic
disorders, tumors, sexually transmitted diseases, AIDS, traditional medicine, integrated
Chinese and Western medicine, evidence-based medicine, epidemiology and nursing. The
journal also publishes original articles and reviews that report the results of applied and
basic research in elds related to dermatology, such as immunology, physiopathology, cell
biology, pharmacology, medical genetics, and pharmacology of Chinese herbs.
We encourage authors to submit their manuscripts to
WJD
. We will give priority to
manuscripts that are supported by major national and international foundations and those
that are of great basic and clinical signicance.
World Journal of Dermatology
is now indexed in Digital Object Identier.
I-II
Editorial Board
INDEXING/ABSTRACTING
Phytotherapy and psoriasis: Complementary and alternative
medications
Sami A Gabr, Ahmad H Alghadir
Sami A Gabr,
Department of Anatomy, Faculty of Medicine,
Mansoura University, Mansoura 35516, Egypt
Sami A Gabr, Ahmad H Alghadir,
Rehabilitation Research
Chair, King Saud University, Riyadh 11433, Kingdom of Saudi
Arabia
Ahmad H Alghadir,
Department of Rehabilitation Science, Col-
lege of Applied Medical Sciences, King Saud University, Riyadh
11433, Kingdom of Saudi Arabia
Author contributions:
Gabr SA and Alghadir AH contributed to
this paper.
Correspondence to:
Dr. Sami A Gabr,
Rehabilitation Research
Chair, King Saud University, 2454, Riyadh 11433,
Kingdom of Saudi Arabia. nadalab2009@hotmail.com
Telephone:
+966-56-2060018
Fax:
+966-14-698541
Received:
December 23, 2013
Revised:
September 8, 2014
Accepted:
October 14, 2014
Published online:
November 2, 2014
Abstract
Psoriasis comprises severe skin problems affects on
quality of patient’s life. It affects 2% of the general
population with age before 35 years old. Most potent
and cheap psoriatic drugs are still largely unavailable.
Recently, as aresult of the apparent side effects of
chemical drugs, treatments of herbal origin gains the
popularity among patients with skin disorders especially
those for psoriasis. In this review, the uses of comple-
mentary and alternative medications of various topical
herbal formulae with different potency against psoriasis
was greatly assessed. Modified Psoriasis scoring sys-
tems were performed as evident of improvement when
various topical herbal formula including traditional chi-
nese medicine ingredients such as Camptotheca acumi-
nate, Oleum horwathiensis, Capsaicin, furocoumarins,
Curcumin, and Tars were used against psoriasis. Also,
plant extracts of Aleo Vera, and green tea were report-
ed in topical form for the treatment of psoriasis. Most
studies indicated a variety of biological activities of
used herbs depending on their chemical constituents.
This versatile range of biological activities explaining,
the apparent benefits of these herbs in monitoring of
psoriasis.
© 2014 Baishideng Publishing Group Inc. All rights reserved.
Key words:
Psoriasis; Herbal medicine; Skin disorders;
Chinese herbal medicine; Traditional chinese medicine
Core tip:
Herbal medicine plays a significant role in the
treatment of psoriasis; this review gives a shed of light
on some herbal medicine formulae and extracts includ-
ing Aleo Vera, and green tea. These plants extracts
and its formulae exhibited efficiency as anti-psoriasis
agents. This may relate to the varying biological activi-
ties especially tissue repair actions.
Gabr SA, Alghadir AH. Phytotherapy and psoriasis: Complemen-
tary and alternative medications. World J Dermatol 2014; 3(4):
86-91 Available from: URL: http://www.wjgnet.com/2218-6190/
full/v3/i4/86.htm DOI: http://dx.doi.org/10.5314/wjd.v3.i4.86
INTRODUCTION
Psoriasis occurs in most populations with a range of
1%-3%
[1,2]
. As usual, synthesized drugs are more potent in
psoriases, however severe unexpected binary effects will
appeare with long period of drug use. Under advice of
dermatologists, about 50% of psoriatic patients around
the world used complementary interventions
[3-8]
. These
include herbal medicine
[9,10]
; which applied to psoriatic
patients with different formulae, topically
[11]
; internally
[12]
;
and in combination with other forms like acitretin
[13]
. The
biological activities of these constituents were discussed
in most literatures
[14,15]
. Whereas these interventions were
prescribed to patients alone or in combinations with dif-
ferent forms
[16,17]
, to perform the targeted therapeutic ef-
fect with limited side effects.
Due to the benecial prospects of traditional chinese
MINIREVIEWS
86 November 2, 2014
|
Volume 3
|
Issue 4
|
WJD
|
www.wjgnet.com
Submit a Manuscript: http://www.wjgnet.com/esps/
Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx
DOI: 10.5314/wjd.v3.i4.86
World Journal of
Dermatology
W J
D
World J Dermatol 2014 November 2; 3(4): 86-91
ISSN 2218-6190 (online)
© 2014 Baishideng Publishing Group Inc. All rights reserved.V
medicine (TCM), it was applied in management of vari-
ous dermatological conditions
[18]
. However, much con-
cerns should performed regarding the safety of Chinese
herbal treatment. Whereas, a bnormal actions as liver tox-
icity was reported during treatment
[19-21]
. So, the biological
activities of some plant extracts used alone or in different
combination forms against psoriasis were greatly report-
ed in this review.
PSORIASIS
According to the type of diagnosis, it was reported as
dermal disorders with varying shapes and severe lesions.
This disease prevails a mong people with age ranges from
15-45 years. The extant of disease usually appears with
chronic symptoms
[22]
. Many factors ranged between ge-
netic, apoptotic, cellular, and immunological parameters
were attributed with the pathological severity of the dis-
ease
[23-25]
. The diagnosis of the disease depends manily
up on the type, location, and area of lesions or plaques.
These parameters were included in many disease scoring
systems. The most useful one is psoriasis area and sever-
ity index score which evaluated to measure disease sever-
ity especially during treatment trials
[26-32]
.
HERBAL MEDICINE AND PSORIASIS
Traditional Chinese medicine and psoriasis
For most dermatologic disorders, TCM with different
formulations were used as an alternative method of
therapy
[33]
. Each part of the palnt can be used as source
for herbal remedies to words many diseases
[34,35]
. The di-
versity of both function and plant parts used, promotes
specialists developing new forms of biologically active
constituents with minimum hazards
[7,36]
. Whereas, natu-
ral plants provide the essential requirements for human
safty. It was reported that TCM is special good choice for
many patients which in turn requires a well experienced
dermatologists to select the more convenient TCM
[37]
.
So, with TCM patients can be treated safely with little
side effects
[38]
. The use of TCM in various forms to treat
psoriasis depend mainly on the type of disease. Whereas
each type has the recommended and denite mixture of
herbs for treatment
[39]
.
Local formulae of indigo plant was efciently used to
treat patients with severe psoriasis. However, recent ideas
were discussed to enhance the potency of this crude
herb by preparing extracts with better convenience and
absorption
[40]
. Camptotheca acuminata decne is another
example of active topical agents in china
[41]
. The biologi-
cal activities of this herb mainly due to its alkaloids con-
tent with antineoplastic activities
[42]
. In open clinical trials,
the efciency of this topical agent was applied for many
cases with psoriasis. The data showed that Camptotheca
acuminate decne was signicantly more effective with no-
ticed possible enhancement of post inammatory hyper-
pigmentation
[43]
. Whereas, in another study a hazard ef-
fect like dermal allergy was reported against camptotheca
acuminate decne which depends mainly on the type
and disease intinisty
[44-47]
. Besides of local trials, some
injectable forms of TCMs like Radix macrotomiae seu
Lithospermi was used with better potent and minimum
side effects against psoriasis compared to other forms of
therapeutic modalities
[7]
. Similar to Western medications,
another type of TCMs were used in capsules or tablets
forms for monotherapies or in groups of herbs with
higher safty and efciency. It was found that, three years
follow-up of psoriatic cases treated orally with TCM
showed convenient results with no hematological or bio-
chemical abnormalities compared to chemotherapeutic
agents
[19,48]
.
Extensive growing evidence was reported for using
natural plant forms to treat psoriatic patients. Comple-
mentary and alternative medicine (CAM) was used by
most patients as a complementary treatment along with
conventional treatment. So, teaching of CAM should be
integrated into the dermatology residency curriculum,
and dermatologists need to increase their awareness of
CAM use by their patients in order to improve therapeu-
tic communication
[49]
.
Some medicinal plants formulations with probable anti-
psoriatic activity
Aloe vera extract:
The plant characterized by its suc-
culent pulpy leaves which contain clear gel. This plant
was used since ancient times as potent remedy for many
diseases
[47,48]
. The versatile range of its active constituents
as analgesic, antipruritic, wound healing and anti-inam-
matory promotes its use as good anti-psoriatic agent
[50]
.
In double-blind, placebo-controlled study, 0.5% of
local forms of Aloe vera extract were subjected for the
treatment of psoriasis with diagnostic scores between 4.8
and 16.7 (mean 9.3). The data concluded that 0.5% of the
extract has higher efciency with no hazards, and could
be used as successful herbal treatment against psoriasis
[51]
.
However, in other study a commercial Aloe vera gel form
showed modest effective treatment against psoriasis
[52]
.
Oleum horwathiensis formula:
Oleum horwathiensis
formula contains many herbal constituents which showed
higher potency in local forms against psoriasis. These
constituents are; Achillaea herba, allium sativum, Ca-
lendula os, Taraxaci radix, Urtica folium and Veronica
ofcinalis. This herb was applied locally to treat psoriasis
with varying severity. The results showed a promising ef-
fect against disease severity after 12 wk
[53]
.
Capsaicin formula:
It is the most popular active con-
stituent present in cayenne pepper (C. frutescens) showed
a probable activity towords psoriasis
[54]
, through activa-
tion of cellular apoptotic factors
[55]
. Zero point zero two
ve percent of this formula was applied as local cream
to enhance the psoriatic status of patients with varying
disease intinisty. The data obtained showed an obvious
decrease in disease severity within short period of time,
however a minimum hazard effect like local site burning
87
November 2, 2014
|
Volume 3
|
Issue 4
|
WJD
|
www.wjgnet.com
Gabr SA
et al
. Herbal medicine as anti-psoriatic agents
was reported, so the formulae was advised to be applied
for only 2 successive days
[56,57]
.
Furocoumarins formula:
This formula contains many
active agents obtained from different herbal plants in-
cluding Ammi majus. The anti psoriatic activity of this
formula depends mainly on photoactivation of furocou-
marins
via
ultraviolet A (UV-A, 320-400 nm) when ap-
plied either locally or in oral forms. The activity mainly
depend up on activation of skin cell apoptosis
via
pho-
tochemical linkage with DNA strands and in turn DNA
fragmentation. Consequently, a reduction in overexpres-
sion of inflammatory and proliferative proteins was re-
ported within psoriatic lesions
[58]
. These activity was fur-
ther investigated in relation to standard therapy, the data
obtained showed similar enhancement of disease prole
with minimum side effects
[59,60]
.
Curcumin formula of turmeric (Curcuma longa):
This
active formula is extracted from the rhizome of Curcuma
longa plant, it is the most potent polyphenolic compound
present as fumaric acid
[61]
. The extract is characterized by
its versatile activities ranged between anti-inflammatory,
antioxidant, antitumor, and anti microbial activities
[33]
, the
mode of action against tumor is through regulation of
the role of some cellular and immunological parameters
during cell cycle and apoptosis
[62]
. For centuries, it was
reported that Turmeric was applied to heal wounds and
reduce scare formation
[63]
. Similary, curcumin showed a
signicant enhancement of psoriatic lesions when applied
locally on diseased skin or orally through capsules. The
extract worked
via
induction of skin cell apoptosis
[64-67]
.
Tars formula:
It is one of the most efcient herbal for-
mula applied since past times to treat skin disorders. This
active ingredient was extracted from many herbal plants
like birch (Betula spp.), beech (Fagus spp.), or juniper
(Juniperus spp.) trees. The extract was applied as anti-
psoriatic agent in different forms with 5%-10% concen-
tration. The improvement capacity of extract depends
on photoactivation mechanism using UV-B with varying
light intinisty
[68]
.
Green tea potential benefits for psoriasis:
Tea con-
sidered the second worldwide beverage next to water. It
consumed as green, black, or Oolong tea. It was reported
that green tea is the most important agent targeting hu-
man health
[69]
. This may be related to its higher content
of polyphenolic compounds, like avanols and catechins,
whereas dried green tea leaves produce more than 30%
of these active constituents. Most studies indicated that
green tea constituents have awide range of medical uses
as antioxidant, antimicrobial, anti-tumor, anti-inamma-
tory, and thermogenic agents
[70,71]
. The vriable actions of
green tea constituents along with its photo suppression
action promotes dermatologists to use it as conventional
treatment for skin diseases, especially psoriasis
[72-75]
.
The treatment of skin with green tea extracts protect
the skin from developing skin cancer through damaging
DNA
via
photochemical action of ultraviolet A radia-
88 November 2, 2014
|
Volume 3
|
Issue 4
|
WJD
|
www.wjgnet.com
Topical application
GTP or EGCG
GTP or EGCG act as
Growth regulator Differentiation inducer Apoptosis inhibitor
EGF
EGF-R
Epiregulin
VEGF-R2
FGF2
EPS8
ODC
AMD1
p57/KIP2
Keratins
Filaggrin
Involucrin
Transglutaminase
Caspase 14
HSP70
GADD45
β
Rb/E2F1, p21
p53, TRADD
c-myc, COX2
Ref-1, TNF-R
DEFCAP, CARD9
CARD10
Differentiation and barrier formation
Figure 1 Green tea effects on human epidermal keratinocytes in molecular and immune response levels
[85-87]
. EGCG: Epigallocatechin-3-gallate; GTP: Green
tea polyphenols; AMD1: Adenosylmethionine decarboxylase 1; CARD: Caspase recruitment domain; COX2: Cyclooxygenase-2; EGF-R: Epidermal growth factor
receptor; EPS8: A substrate for the epidermal growth factor receptor kinase; GADD45
β
: Growth arrest and DNA damage 45
β
; HSP70: Heat-shock protein 70; ODC:
Ornithine decarboxylase; Rb: Retinoblastoma; TNF-R: Tumor necrosis factor receptor; TRADD: Tumor necrosis factor receptor 1 associated death domain protein;
VEGF-R2: Vascular epithelial growth factor-receptor 2; FGF2: Fibroblast growth factor 2; DEFCAP: Death-effector lament-forming caspase protein.
Gabr SA
et al
. Herbal medicine as anti-psoriatic agents
89 November 2, 2014
|
Volume 3
|
Issue 4
|
WJD
|
www.wjgnet.com
als. J Tianjin Med Univ 2008;
14
: 487-491
14
Reuter J
, Wöle U, Weckesser S, Schempp C. Which plant for
which skin disease? Part 1: Atopic dermatitis, psoriasis, acne,
condyloma and herpes simplex. J Dtsch Dermatol Ges 2010;
8
:
788-796 [PMID: 20707875 DOI: 10.1111/j.1610-0387.2010.0749
6.x]
15
Tse TW
. Use of common Chinese herbs in the treatment
of psoriasis. Clin Exp Dermatol 2003;
28
: 469-475 [PMID:
12950329 DOI: 10.1046/j.1365-2230.2003.01322.x]
16
Chan BC
, Hon KL, Leung PC, Sam SW, Fung KP, Lee MY,
Lau HY. Traditional Chinese medicine for atopic eczema:
PentaHerbs formula suppresses inammatory mediators re-
lease from mast cells. J Ethnopharmacol 2008;
120
: 85-91 [PMID:
18725279 DOI: 10.1016/j.jep.2008.07.034]
17
Sucher NJ
. The application of Chinese medicine to novel
drug discovery. Expert Opin Drug Discov 2013;
8
: 21-34 [PMID:
23170842 DOI: 10.1517/17460441]
18
Bedi MK
, Shenefelt PD. Herbal therapy in dermatology.
Arch Dermatol 2002;
138
: 232-242 [PMID: 11843645 DOI:
10.1001/archderm.138.2.232]
19
Sheehan MP
, Atherton DJ. A controlled trial of traditional
Chinese medicinal plants in widespread non-exudative atop-
ic eczema. Br J Dermatol 1992;
126
: 179-184 [PMID: 1536784
DOI: 10.1111/j.1365-2133.1992.tb07817.x]
20
Armstrong NC
, Ernst E. The treatment of eczema with Chi-
nese herbs: a systematic review of randomized clinical trials.
Br J Clin Pharmacol 1999;
48
: 262-264 [PMID: 10417508 DOI:
10.1046/j.13]
21
Boneberger S
, Rupec RA, Ruzicka T. Complementary the-
rapy for atopic dermatitis and other allergic skin diseases:
facts and controversies. Clin Dermatol 2010;
28
: 57-61 [PMID:
20082952]
22
von de Kerkof P
, Schalkwijk J. Psoriasis. In: Rapini RP,
Jorizzo JL, Bolognia JL, eds. Dermatology. 2nd ed. Mosby
Elsevier: Spain, 2008: 125-149
23
Farber EM
, Bright RD, Nall ML. Psoriasis. A questionnaire
survey of 2,144 patients. Arch Dermatol 1968;
98
: 248-259
[PMID: 5673885]
24
Coimbra S
, Figueiredo A, Castro E, Rocha-Pereira P, Santos-
Silva A. The roles of cells and cytokines in the pathogenesis
of psoriasis. Int J Dermatol 2012;
51
: 389-395; quiz 395-398
[PMID: 22435425 DOI: 10.1111/j.1365-4632.2011.05154.x]
25
Raychaudhuri SP
. A cutting edge overview: psoriatic dis-
ease. Clin Rev Allergy Immunol 2013;
44
: 109-113 [PMID:
22359072 DOI: 10.1007/s12016-012-8309-z]
26
Louden BA
, Pearce DJ, Lang W, Feldman SR. A Simplied
Psoriasis Area Severity Index (SPASI) for rating psoriasis
severity in clinic patients. Dermatol Online J 2004;
10
: 7 [PMID:
15530297]
27
Fleischer AB
, Rapp SR, Reboussin DM, Vanarthos JC, Feld-
man SR. Patient measurement of psoriasis disease severity
with a structured instrument. J Invest Dermatol 1994;
102
:
967-969 [PMID: 8006462 DOI: 10.1111/1523-1747.ep12384205]
28
Faust HB
, Gonin R, Chuang TY, Lewis CW, Melfi CA, Fa-
rmer ER. Reliability testing of the dermatology index of
disease severity (DIDS). An index for staging the severity of
cutaneous inflammatory disease. Arch Dermatol 1997;
133
:
1443-1448 [PMID: 9371030]
29
Sugai J
, Ozawa A, Kawakubo Y, Iizuka M, Miyahara M,
Ohkido M. New method for determining prognosis of pa-
tients with psoriasis (E-PAP). J Dermatol Sci 1998;
16
: 165-169
[PMID: 9459130 DOI: 10.1016/S0923-1811(97)00047-9]
30
Kirby B
, Fortune DG, Bhushan M, Chalmers RJ, Grifths CE.
The Salford Psoriasis Index: an holistic measure of psoriasis
severity. Br J Dermatol 2000;
142
: 728-732 [PMID: 10792223
DOI: 10.1046/j.1365-2133.2000.03418.x]
31
Harari M
, Shani J, Hristakieva E, Stanimirovic A, Seidl W,
Burdo A. Clinical evaluation of a more rapid and sensitive
Psoriasis Assessment Severity Score (PASS), and its compari-
son with the classic method of Psoriasis Area and Severity
tion
[76]
. It was reported that green tea or its active con-
stituents when applied in psoriatic skin, promotes the
formation of skin cell apoptosis
via
activation of certain
apoptotic biological enzymes included in epidermal dif-
ferentiation, cornication of the epidermal keratinocytes
and skin barrier formation
[77-82]
. Finally, the activity of
green tea against psoriasis summarized in, activation of a
set of apoptotic genes which promotes epidermal differ-
entiation and skin barrier formation along with enhance-
ment of the healing process as in Figure 1
[83-87]
.
CONCLUSION
Clinical trials proved a significant potential benefits of
herbs against psoriasis which appeared relatively safe. The
varied biological activities of these topical herbal formu-
lae may relate to its apparent benets in psoriasis. Most
advanced trials like molecular screening were needed for
discovering new leads and drug safe candidates from
plant natural products against psoriasis.
REFERENCES
1
Christophers E
. Psoriasis--epidemiology and clinical spec-
trum. Clin Exp Dermatol 2001;
26
: 314-320 [PMID: 11422182
DOI: 10.1046/j.1365-2230.2001.00832.x]
2
Langley RG
, Krueger GG, Griffiths CE. Psoriasis: epide-
miology, clinical features, and quality of life. Ann Rheum
Dis 2005;
64
Suppl 2: ii18-ii23; discussion ii24-ii25 [PMID:
15708928 DOI: 10.1136/ard.2004.033217]
3
Baron SE
, Goodwin RG, Nicolau N, Blackford S, Goulden
V. Use of complementary medicine among outpatients with
dermatologic conditions within Yorkshire and South Wales,
United Kingdom. J Am Acad Dermatol 2005;
52
: 589-594
[PMID: 15793507]
4
Fuhrmann T
, Smith N, Tausk F. Use of complementary and
alternative medicine among adults with skin disease: updated
results from a national survey. J Am Acad Dermatol 2010;
63
:
1000-1005 [PMID: 20933300 DOI: 10.1016/j.jaad.2009.12.009]
5
Jensen P
. Use of alternative medicine by patients with atopic
dermatitis and psoriasis. Acta Derm Venereol 1990;
70
: 421-424
[PMID: 1980977]
6
Smith N
, Weymann A, Tausk FA, Gelfand JM. Complemen-
tary and alternative medicine for psoriasis: a qualitative re-
view of the clinical trial literature. J Am Acad Dermatol 2009;
61
: 841-856 [PMID: 19664846 DOI: 10.1016/j.jaad.2009.04.029]
7
Lin XR
. Psoriasis in China. J Dermatol 1993;
20
: 746-755
[PMID: 8120236]
8
Ouyang H
. Progress in the treatment of psoriasis with TCM
or western medicine. Guid J Tradit Chin Med Pharm 2007;
13
:
1-8
9
Steele T
, Rogers CJ, Jacob SE. Herbal remedies for psoria-
sis: what are our patients taking? Dermatol Nurs 2007;
19
:
448-450, 457-463 [PMID: 18286859]
10
Traub M
, Marshall K. Psoriasis--pathophysiology, conven-
tional, and alternative approaches to treatment. Altern Med
Rev 2007;
12
: 319-330 [PMID: 18069901]
11
Li N
, Li YQ, Li HY, Guo W, Bai YP. Efcacy of externally ap-
plied Chinese herbal drugs in treating psoriasis: a systematic
review. Chin J Integr Med 2012;
18
: 222-229 [PMID: 22466949]
12
May BH
, Zhang AL, Zhou W, Lu CJ, Deng S, Xue CC. Oral
herbal medicines for psoriasis: a review of clinical studies.
Chin J Integr Med 2012;
18
: 172-178 [PMID: 22466940 DOI:
10.1007/s11655-012-1008-z]
13
Feng X
, Xu L. Traditional Chinese medicine plus a citretin
for psoriasis: a Meta-analysis on randomized controlled tri-
Gabr SA
et al
. Herbal medicine as anti-psoriatic agents
90 November 2, 2014
|
Volume 3
|
Issue 4
|
WJD
|
www.wjgnet.com
Index (PASI), before and after climatotherapy at the Dead-
Sea. Int J Dermatol 2000;
39
: 913-918 [PMID: 11168660]
32
Callen JP
, Krueger GG, Lebwohl M, McBurney EI, Mease
P, Menter A, Paller AS, Pariser DM, Weinblatt M, Zimmer-
man G. AAD consensus statement on psoriasis therapies. J
Am Acad Dermatol 2003;
49
: 897-899 [PMID: 14576671 DOI:
10.1016/S0190-9622(03)01870-X]
33
Koo J
, Arain S. Traditional Chinese medicine for the treat-
ment of dermatologic disorders. Arch Dermatol 1998;
134
:
1388-1393 [PMID: 9828872]
34
Fleischer AB
, Feldman SR, Rapp SR, Reboussin DM, Exum
ML, Clark AR. Alternative therapies commonly used within
a population of patients with psoriasis. Cutis 1996;
58
:
216-220 [PMID: 8886537]
35
Li FQ
, Fang FY, Jian ZY. Cases suffering from psoriasis
treated with traditional Chinese medicine and long wave
ultraviolet. Chin J Phys Ther 1983;
6
: 144-145
36
Chen LZ
. Treating 23 cases of psoriasis with indirubin tab-
lets. J Clin Dermatol 1981;
10
: 157-158
37
Jerner B
, Skogh M, Vahlquist A. A controlled trial of acu-
puncture in psoriasis: no convincing effect. Acta Derm Vene-
reol (Stockh) 1997;
77
: 154-156
38
Rosted P
. Treatment of skin diseases with acupuncture: a
review. J Dermatol Treat 1995;
6
: 241-242 [DOI: 10.3109/09546
639509086853]
39
Zhao F
, Wang P, Hua S. Treatment of psoriasis with acu-
puncture and cupping therapy. Chin Acupunct Moxibust
1991;
11
: 16-19
40
Lin YK
, Chang CJ, Chang YC, Wong WR, Chang SC, Pang
JH. Clinical assessment of patients with recalcitrant psoria-
sis in a randomized, observer-blind, vehicle-controlled trial
using indigo naturalis. Arch Dermatol 2008;
144
: 1457-1464
[PMID: 19015420 DOI: 10.1001/archderm.144.11.1457]
41
Institute of Dermatology, Sichuan Province
. An observa-
tion of treating 33 cases of psoriasis with camtothecin. Sich-
uan Bull Chn Herb 1973;
2
: 7
42
Horwitz SB
. Camptothecin. In: Sartorelli AC, Johns DG,
eds. Antineoplastic and Immunosuppressive Agents, Part II.
New York, NY: Springer-Verlag NY Inc, 1976: 649-656
43
Xarin L
. Clinical observation and experimental study on the
effect of camptotheca acuminate tincture in treating psoria-
sis. Chinese Journal of Dermatology 1982;
15
: 210-212
44
Ng SK
. Topical traditional Chinese medicine. A report
from Singapore. Arch Dermatol 1998;
134
: 1395-1396 [PMID:
9828873 DOI: 10.1001/archderm.134.11.1395]
45
Zhang H
, Gu J. Progress of experimental study on treatment
of psoriasis by Chinese medicinal monomer and single or
compound recipe in Chinese materia medica. Chin J Integr
Med 2007;
13
: 312-316 [PMID: 18180899 DOI: 10.1007/s11655-
007-0312-5]
46
Xu Y
. Dermatology in Traditional Chinese Medicine. St. Al-
bans, UK: Donica Publishing Ltd., 2004
47
Shishodia S
, Sethi G, Aggarwal BB. Curcumin: getting back
to the roots. Ann N Y Acad Sci 2005;
1056
: 206-217 [PMID:
16387689 DOI: 10.1196/annals.1352.010]
48
Zeng QT
. Camptotheca acuminata decne. In: Wang YS, ed.
The Pharmacology and Application of Chinese Traditional
Medicine. Beijing, China: Peoples Health Publishing, 1983:
142-1151
49
Zhao WP
. Clinical observation of 206 cases of psoriasis treat-
ed with Bian Zheng Shi Zhi of traditional Chinese medicine.
J Trad Chin Med 1989;
30
: 31-32
50
Ben-Arye E
, Ziv M, Frenkel M, Lavi I, Rosenman D. Com-
plementary medicine and psoriasis: linking the patient’s out-
look with evidence-based medicine. Dermatology 2003;
207
:
302-307 [PMID: 14571074 DOI: 10.1159/000073094]
51
Klein AD
, Penneys NS. Aloe vera. J AM Acad Dermatol 1988;
18
: 714-720 [DOI: 10.1016/S0190-9622(88)70095-X]
52
Shelton RM
. Aloe vera. Its chemical and therapeutic prop-
erties. Int J Dermatol 1991;
30
: 679-683 [PMID: 1823544 DOI:
10.1111/j.1365-4362.1991.tb02607.x]
53
Duke JA
. CRC Handbook of Medicina1 Herbs. Boca Raton,
FL: CRC Press, 1985: 31-32
54
Syed TA
, Ahmad SA, Holt AH, Ahmad SA, Ahmad SH,
Afzal M. Management of psoriasis with Aloe vera extract
in a hydrophilic cream: a placebo-controlled, double-blind
study. Trop Med Int Health 1996;
1
: 505-509 [PMID: 8765459]
55
Paulsen E
, Korsholm L, Brandrup F. A double-blind, pla-
cebo-controlled study of a commercial Aloe vera gel in the
treatment of slight to moderate psoriasis vulgaris. J Eur Acad
Dermatol Venereol 2005;
19
: 326-331 [PMID: 15857459 DOI:
10.1111/j.1468-3083.2004.01186.x]
56
Lassus A
, Forsström S. A double-blind study comparing ole-
um horwathiensis with placebo in the treatment of psoriasis.
J Int Med Res 1991;
19
: 137-146 [PMID: 1864450]
57
McGufn M
, Hobbs C, Upton R, Goldberg A, editors. Bo-
tanical Safety Handbook. Boca Raton, FL: CRC Press, 1997
58
Surh YJ
, Han SS, Keum YS, Seo HJ, Lee SS. Inhibitory effects
of curcumin and capsaicin on phorbol ester-induced acti-
vation of eukaryotic transcription factors, NF-kappaB and
AP-1. Biofactors 2000;
12
: 107-112 [PMID: 11216470]
59
Bernstein JE
, Parish LC, Rapaport M, Rosenbaum MM, Roe-
nigk HH. Effects of topically applied capsaicin on moderate
and severe psoriasis vulgaris. J Am Acad Dermatol 1986;
15
:
504-507 [PMID: 3760276 DOI: 10.1016/S0190-9622(86)70201-6]
60
Ellis CN
, Berberian B, Sulica VI, Dodd WA, Jarratt MT, Katz
HI, Prawer S, Krueger G, Rex IH, Wolf JE. A double-blind
evaluation of topical capsaicin in pruritic psoriasis. J Am
Acad Dermatol 1993;
29
: 438-442 [PMID: 7688774 DOI: 10.1016
/0190-9622(93)70208-B]
61
Van Wyk B
, Wink M. Medicinal Plants of the World. Port-
land, OR: Timber Press, 2004
62
Huang MT
, Smart RC, Wong CQ, Conney AH. Inhibitory
effect of curcumin, chlorogenic acid, caffeic acid, and ferulic
acid on tumor promotion in mouse skin by 12-O-tetradec-
anoylphorbol-13-acetate. Cancer Res 1988;
48
: 5941-5946 [PMID:
3139287]
63
Chaturvedi TP
. Uses of turmeric in dentistry: an update. In-
dian J Dent Res 2009;
20
: 107-109 [PMID: 19336870]
64
Heng MC
, Song MK, Harker J, Heng MK. Drug-induced
suppression of phosphorylase kinase activity correlates with
resolution of psoriasis as assessed by clinical, histological
and immunohistochemical parameters. Br J Dermatol 2000;
143
: 937-949 [PMID: 11069500 DOI: 10.1046/j.1365-2133.2000.
03767.x]
65
Aziz HA
, Peh KK, Tan YT. Solubility of core materials in
aqueous polymeric solution effect on microencapsulation of
curcumin. Drug Dev Ind Pharm 2007;
33
: 1263-1272 [PMID:
18058323 DOI: 10.1080/03639040701483967]
66
Kuroda Y
, Hara Y. Antimutagenic and anticarcinogenic
activity of tea polyphenols. Mutat Res 1999;
436
: 69-97 [DOI:
10.1016/S1383-5742(98)00019-2]
67
Alschuler L
. Green Tea: Healing tonic. Am J Natur Med 1998;
5
: 28-31
68
Graham HN
. Green tea composition, consumption, and
polyphenol chemistry. Prev Med 1992;
21
: 334-350 [PMID:
1614995 DOI: 10.1016/0091-7435(92)90041-F]
69
Ichihashi M
, Ahmed NU, Budiyanto A, Wu A, Bito T, Ueda
M, Osawa T. Preventive effect of antioxidant on ultraviolet-
induced skin cancer in mice. J Dermatol Sci 2000;
23
Suppl 1:
S45-S50 [PMID: 10764992 DOI: 10.1016/S0923-1811(00)00083
-9]
70
Balasubramanian S
, Emova T, Eckert RL. Green tea poly-
phenol stimulates a Ras, MEKK1, MEK3, and p38 cascade
to increase activator protein 1 factor-dependent involucrin
gene expression in normal human keratinocytes. J Biol Chem
2002;
277
: 1828-1836 [PMID: 11698415]
71
Bikle DD
, Ng D, Tu CL, Oda Y, Xie Z. Calcium- and vitamin
D-regulated keratinocyte differentiation. Mol Cell Endocrinol
2001;
177
: 161-171 [PMID: 11377831 DOI: 10.1016/S0303-
Gabr SA
et al
. Herbal medicine as anti-psoriatic agents
91 November 2, 2014
|
Volume 3
|
Issue 4
|
WJD
|
www.wjgnet.com
7207(01)00452-X]
72
Bollinger Bollag W
, Bollag RJ. 1,25-Dihydroxyvitamin D(3),
phospholipase D and protein kinase C in keratinocyte dif-
ferentiation. Mol Cell Endocrinol 2001;
177
: 173-182 [PMID:
11377832 DOI: 10.1016/S0303]
73
Nickoloff BJ
, Qin JZ, Chaturvedi V, Bacon P, Panella J, Den-
ning MF. Life and death signaling pathways contributing
to skin cancer. J Investig Dermatol Symp Proc 2002;
7
: 27-35
[PMID: 12518789 DOI: 10.1046/j.1523-1747.2002.19633.x]
74
Lippens S
, Kockx M, Knaapen M, Mortier L, Polakowska
R, Verheyen A, Garmyn M, Zwijsen A, Formstecher P,
Huylebroeck D, Vandenabeele P, Declercq W. Epidermal
differentiation does not involve the pro-apoptotic execu-
tioner caspases, but is associated with caspase-14 induction
and processing. Cell Death Differ 2000;
7
: 1218-1224 [PMID:
11175259]
75
Madison KC
. Barrier function of the skin: “la raison d’être
of the epidermis. J Invest Dermatol 2003;
121
: 231-241 [PMID:
12880413 DOI: 10.1046/j.1523-1747.2003.12359.x]
76
Zhao JF
, Zhang YJ, Jin XH, Athar M, Santella RM, Bickers
DR, Wang ZY. Green tea protects against psoralen plus ul-
traviolet A-induced photochemical damage to skin. J Invest
Dermatol 1999;
113
: 1070-1075 [PMID: 10594754]
77
Ahmad M
, Srinivasula SM, Hegde R, Mukattash R, Fer-
nandes-Alnemri T, Alnemri ES. Identication and character-
ization of murine caspase-14, a new member of the caspase
family. Cancer Res 1998;
58
: 5201-5205 [PMID: 9823333]
78
Pistritto G
, Jost M, Srinivasula SM, Baffa R, Poyet JL, Kari
C, Lazebnik Y, Rodeck U, Alnemri ES. Expression and tran-
scriptional regulation of caspase-14 in simple and complex
epithelia. Cell Death Differ 2002;
9
: 995-1006 [PMID: 12181750
DOI: 10.1038/sj.cdd.4401061]
79
Eckhart L
, Ban J, Fischer H, Tschachler E. Caspase-14: analy-
sis of gene structure and mRNA expression during keratino-
cyte differentiation. Biochem Biophys Res Commun 2000;
277
:
655-659 [PMID: 11062009 DOI: 10.1006/bbrc.2000.3698]
80
Rendl M
, Ban J, Mrass P, Mayer C, Lengauer B, Eckhart L,
Declerq W, Tschachler E. Caspase-14 expression by epider-
mal keratinocytes is regulated by retinoids in a differentia-
tion-associated manner. J Invest Dermatol 2002;
119
: 1150-1155
[PMID: 12445205 DOI: 10.1046/j.1523-1747.2002.19532.x]
81
Lippens S
, VandenBroecke C, Van Damme E, Tschachler E,
Vandenabeele P, Declercq W. Caspase-14 is expressed in the
epidermis, the choroid plexus, the retinal pigment epithe-
lium and thymic Hassall’s bodies. Cell Death Differ 2003;
10
:
257-259 [PMID: 12700654 DOI: 10.1038/sj.cdd.4401141]
82
Hsu S
, Yamamoto T, Borke J, Walsh DS, Singh B, Rao S,
Takaaki K, Nah-Do N, Lapp C, Lapp D, Foster E, Bollag WB,
Lewis J, Wataha J, Osaki T, Schuster G. Green tea polyphe-
nol-induced epidermal keratinocyte differentiation is associ-
ated with coordinated expression of p57/KIP2 and caspase
14. J Pharmacol Exp Ther 2005;
312
: 884-890 [PMID: 15537824
DOI: 10.1124/jpet.104.076075]
83
Walsh DS
, Borke JL, Singh BB, Do NN, Hsu SD, Balagon
MV, Abalos RM. Psoriasis is characterized by altered epi-
dermal expression of caspase 14, a novel regulator of ke-
ratinocyte terminal differentiation and barrier formation. J
Dermatol Sci 2005;
37
: 61-63 [PMID: 15619438 DOI: 10.1016/j.
jdermsci.2004.10.003]
84
Hsu S
, Lewis JB, Borke JL, Singh B, Dickinson DP, Caugh-
man GB, Athar M, Drake L, Aiken AC, Huynh CT, Das BR,
Osaki T, Schuster GS. Chemopreventive effects of green tea
polyphenols correlate with reversible induction of p57 ex-
pression. Anticancer Res 2003;
21
: 3743-3748 [PMID: 11911242]
85
Hsu S
, Bollag WB, Lewis J, Huang Q, Singh B, Sharawy M,
Yamamoto T, Schuster G. Green tea polyphenols induce dif-
ferentiation and proliferation in epidermal keratinocytes. J
Pharmacol Exp Ther 2003;
306
: 29-34 [PMID: 12663686 DOI:
10.1124/jpet.103.049734]
86
Wei H
, Zhang X, Zhao JF, Wang ZY, Bickers D, Lebwohl
M. Scavenging of hydrogen peroxide and inhibition of ul-
traviolet light-induced oxidative DNA damage by aqueous
extracts from green and black teas. Free Radic Biol Med 1999;
26
: 1427-1435 [PMID: 10401606 DOI: 10.1016/S0891-5849]
87
Proniuk S
, Liederer BM, Blanchard J. Preformulation study
of epigallocatechin gallate, a promising antioxidant for
topical skin cancer prevention. J Pharm Sci 2002;
91
: 111-116
[PMID: 11782902 DOI: 10.1002/jps.10009]
P- Reviewer
: Manolache L, Naldi L
S- Editor
:
Ji FF
L- Editor
: A
E- Editor
:
Liu SQ
Gabr SA
et al
. Herbal medicine as anti-psoriatic agents
© 2014 Baishideng Publishing Group Inc. All rights reserved.
Published by
Baishideng Publishing Group Inc
8226 Regency Drive, Pleasanton, CA 94588, USA
Telephone: +1-925-223-8242
Fax: +1-925-223-8243
E-mail: bpgofce@wjgnet.com
Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx
http://www.wjgnet.com
... For centuries plant extracts have been used in the identification and research of potential new drugs [7], and during the last decade, there has been a remarkable and growing interest in using plant extracts, as alternative medicines, for the management of psoriasis. This has been due to the anti-proliferative [8,9], differentiation-inducing [9], and anti-inflammatory activities identified in several plant extracts [10,11]. Furthermore, plant extracts could potentially provide a safe alternative to currently prescribed therapies [12,13]. ...
Article
Ethnopharmacological relevance: Zanthoxylum bungeanum (ZB), a Chinese herb medicine, has been shown to possess a wide range of biological activities including anti-tumor, anti-inflammatory, and anti-microbial activity and has long been used to treat a variety of skin diseases including psoriasis. However, the underlying mechanism of action has not been systematically elucidated. Aim of the study: to analyze the chemical composition of the hydro-distilled Zanthoxylum bungeanum essential oil (ZBEO), and to investigate its anti-proliferative activity on HaCaT cells as well as the underlying anti-psoriasis mechanisms. Materials and methods: The chemical composition of ZBEO was analyzed with gas chromatography coupled to mass spectrometry (GC-MS). HaCaT cells was exposed to different dose of ZBEO added in medium prior to morphologic features analysis as well as cell cycle arrest examination with Flow cytometry. Western blot analysis was employed to estimate the expression level of proteins including caspase-8/9/3, PARP, Bax and Bcl-2. Results: Thirty-nine compounds of the ZBEO were identified GC-MS. ZBEO-treated HaCaT cells showed typical apoptotic morphologic features by DAPI staining assay. The ZBEO significantly inhibited proliferation of HaCaT cells in a dose- and time-dependent manner and induced S phase arrest apoptosis in HaCaT cells. Furthermore, western blot analysis revealed that the ZBEO increased expression of cleaved caspase-8/9/3, PARP, and Bax, decreased Bcl-2 levels. Conclusion: ZBEO inhibits the proliferation of HaCaT cells, resulting from the induction of cellular apoptosis through both intrinsic and extrinsic pathways. ZBEO is a potential candidate that may be considered for development into an anti-psoriasis drug.
... For centuries plant extracts have been used in the identification and research of potential new drugs [7], and during the last decade, there has been a remarkable and growing interest in using plant extracts, as alternative medicines, for the management of psoriasis. This has been due to the anti-proliferative [8,9], differentiation-inducing [9], and anti-inflammatory activities identified in several plant extracts [10,11]. Furthermore, plant extracts could potentially provide a safe alternative to currently prescribed therapies [12,13]. ...
Article
Full-text available
In the present study, molecular docking studies of some selected natural products were carried out to identify the potential inhibitors and subsequently to suggest their mechanism of action in relation to P38α mitogen-activated protein kinases (P38α MAPK) enzyme. Psoriasis is an inflammatory disorder characterized by skin hyper-proliferation, differentiation in keratin expression, and increased production of pro-inflammatory cytokines. Increased expression of phosphorylated P38α MAPK in the cytoplasm and nucleus is observed in psoriatic lesions. Twelve natural antipsoriatic agents were included in the study and their molecular docking studies were carried out using AutoDock 4.2 simulator using a Lamarckian genetic algorithm. The crystal structure of P38α MAPK was retrieved from the protein data bank and three-dimensional chemical structures of natural ligands were prepared using ChemSketch 2015. Results indicated that all the natural ligands were fitted into the active site. Hypericin and Catechin (−9.00 and −8.05 kcal/mol, respectively) have shown good binding efficacy among other ligands. However, only Epicatechin interacted with residues in the enzyme required for enzyme inhibition. The study concludes that the Epicatechin effectively inhibited the enzyme and proved itself to be a type-I 1/2 inhibitor of the enzyme among other natural ligands and responsible for the treatment of psoriasis preclinically through this mechanism of action.
Article
Full-text available
Psoriasis is a chronic immune-mediated inflammatory skin disease, in which pruritus is a common feature and also affects the social well-being of individuals with psoriasis significantly. The transient receptor potential cation channel, subfamily V, member 3 (TRPV3) is believed to be involved in hypersensation and generation of itching in the case of psoriasis. The purpose of the present study was to find out suitable anti-pruritic agents and to establish the mechanism of actions of those anti-pruritic agents with the help of molecular docking studies, through which they can alleviate the itching and hypersensitivity problems in psoriasis. An extensive literature survey, pertaining to natural ligands having reported antipsoriatic activity was carried out. The crystal structure of the TRPV3 receptor was retrieved from rcsb.org. 3D structures of selected eleven natural ligands were prepared and optimized by ChemSketch free version 2015. Computational protein-ligand docking studies were carried out by AutoDock 4.2 simulator using the Lamarckian genetic algorithm. In this study, Hypericin showed a higher binding affinity (-8.09 kcal/mol) and fitted into the active pocket of TRPV3. Results revealed that Hypericin might be the candidates to be employed as an anti-pruritic agent in the case of psoriasis to desensitize the TRPV3 ion channel. © 2020, National Institute of Science Communication and Information Resources (NISCAIR). All rights reserved.
Article
Psoriasis is a chronic inflammatory cutaneous disease characterized by clinical manifestations of erythema and white scales. The pathogenesis of psoriasis is not yet clear. Despite a combination of hormonal therapy and physiotherapy used in Western medicine, the condition often relapses after withdrawal of drugs. Traditional Chinese medicine (TCM) has therapeutic features and may be a clinically effective formula by regulating unbalanced immune systems, such as by targeting interleukins. In this paper, we review recent research about how Chinese medicine immunoregulates psoriasis via interleukins, and systematically summarizes the related mechanisms. There are three common pathways leading to psoriasis: (1) Th17 cells secrete IL-17, which is stimulated by IL-23; (2) Th1 cells secrete IL-21, TNF-α and IFN-γ, with the help of Th17 cells; (3) Th22 cells secrete IL-22 under the stimulation of Th17 cells. Clinical and experiment data indicate that TCM could modify psoriasis by antagonizing or regulating interleukin and IL-23/IL-17 axis to inhibit the main pathways.
Article
Introduction: The apparent productivity crisis in the pharmaceutical industry and the economic and political rise of China have contributed to renewed interest in the application of Chinese medicine for drug discovery. Areas covered: The author presents an overview of the historical development and basic principles of theory and practice of Chinese herbal medicine, its materia medica and prescription formulas, and discusses the motivation for and rationale of its application to drug discovery. Furthermore, the author distinguishes the five main approaches to drug discovery from Chinese herbal medicine, based on the decreasing amount and detail of historical and clinical Chinese medicine knowledge that informed the research effort. Expert opinion: Many compounds that have been isolated from the Chinese materia medica exhibit pharmacological activities comparable to pharmaceutical drugs. With the exception of the antimalarial drug artemisinin, however, this knowledge has not led to the successful development of new drugs outside of China. The chance of success in a Chinese medicine-based drug discovery effort will be increased by consideration of the empirical knowledge that has been documented over many centuries in the historical materia medica and prescription literature. Most Chinese medicine-derived compounds affect more than one target and do not correspond to the one compound/one-target drug discovery paradigm. A new frontier is opening up with the development of drugs consisting of combinations of multiple compounds acting on multiple targets under the paradigm of network pharmacology. The ancient practice of combining multiple drugs in prescription formulas can serve as inspirational analogy and a practical guide.
Article
A Practical, Authoritative CompendiumThis handbook catalogs 365 species of herbs having medicinal or folk medicinal uses, presenting whatever useful information has been documented on their toxicity and utility in humans and ani-mals. Plants from all over the world - from common cultivars to rare species - are included in these 700 pages. The toxicity of these species varies, but the safety of each has been formally or informally questioned by the Food and Drug Administration, National Cancer Institute, Department of Agriculture, Drug Enforcement Administra-tion, or Herb Trade Association. Easy-to-Locate Facts and FiguresDesigned to enable fast access to important information, this hand-book presents information in both catalog and tabular forms. In the catalog section, plants are presented alphabetically by scientific name. (The index permits you to locate an herb by its common name.) A detailed sketch of the chief identifying features accompa-nies most catalog entries. For each species the following information, as available, is presented and referenced: Family and colloquial namesChemical contentUses and applications - present and historicalProcessing, distribution, and economic potentialToxicological agents and degree of toxicityPoison symptoms in humans and animalsTreatment and antidotes References to original literature Five Tables of Accessible DataGiven a plant species, you can easily determine its toxins; or, given a toxin, you can discover which plants contain it. These and other data are presented in convenient tabular formats as appendixes to the handbook. Other information contained in these tables include toxicity ranking and other toxicity data (as applicable), such as mode of contact, organs affected, and lethal dose; and proximate analyses of selected foods. These tables are titled: Medicinal Herbs: Toxicity Ranking and PricelistToxins: Their Toxicity and Distribution in Plant GeneraHigh Plant Genera and Their ToxinsPharmacologically Active PhytochemicalsProximate Analyses of Conventional Plant Foods
Article
This review summarizes and criticizes 10 papers concerning the treatment of skin diseases with acupuncture. Despite a high success rate, the results are questioned because of the lack of objective evidence presented.
Article
There is increasing evidence for the extensive use of complementary and alternative medicine (CAM) by patients with psoriasis. Clinical research in the arena of CAM and psoriasis treatment is evolving and includes some randomized controlled trials. To study CAM use among patients with psoriasis attending a dermatology clinic in a major university hospital in northern Israel. Prevalence, reasons for CAM use and its relevance to doctor-patient communication were emphasized. Semistructured interviews were conducted with psoriasis patients in a dermatology clinic. Consent was obtained for 78 patients. Post-visit questionnaires were given to 5 physicians. Seventy-eight patients with psoriasis were interviewed and 77 were studied. Sixty-two percent used CAM. Fifty-eight percent of users had seen a CAM practitioner. The study found a trend of CAM use among patients with psoriasis from Arab compared to Jewish descent (p=0.087). CAM users reported on average 2 different CAM modalities. Herbal medicine and nutritional treatments ranked first, followed by homeopathy, traditional Chinese medicine and nutritional supplements. The main reason for CAM use was stated to be to do everything to heal the disease, followed by a quest for improved quality of life. Others mentioned an interest in a less toxic treatment, disappointment with conventional treatment and stress reduction. Well over half of the study participants and their dermatologists did not initiate a discussion about CAM use. The dermatologists' ability to predict CAM use in their patients was relatively low. There is growing evidence of extensive CAM use among patients with psoriasis. Most patients use CAM as a complementary treatment, rather than an alternative to conventional treatment. Teaching CAM should be integrated into the dermatology residency curriculum. Dermatologists need to increase their awareness of CAM use by their patients in order to improve therapeutic communication.
Article
Phosphorylase kinase (PhK), also known as adenosine triphosphate (ATP)-phosphorylase b phosphotransferase, integrates multiple calcium/calmodulin-dependent signalling pathways, including those involved in cell migration and cell proliferation, while coupling these pathways to glycogenolysis and ATP-dependent phosphorylation, thus ensuring continuing energy supply for these activities. Our laboratory recently reported correlation of elevated PhK activity with psoriatic activity. This study further evaluates the significance of drug-induced suppression of PhK activity on psoriatic activity. PhK activity was assayed in four groups, each with 10 patients: (i) active untreated psoriasis; (ii) resolving psoriasis treated by calcipotriol (Dovonex(R), Bristol Myers Squibb, Princeton, NJ, U.S.A. ), a vitamin D3 analogue and an indirect inhibitor of PhK; (iii) curcumin (diferuloylmethane), a selective PhK inhibitor; and (iv) 10 normal non-psoriatic subjects. PhK activity in units mg-1 protein was highest in active untreated psoriasis (1204 +/- 804.3; mean +/- SD), lower in the calcipotriol-treated group (550.7 +/- 192. 9), lower in curcumin-treated group (207.2 +/- 97.6), and lowest in normal skin (105.4 +/- 44.6). One-way analysis of variance performed on log-transformed PhK activity measure showed significant differences among the four groups, F3,36 = 48.79, P < 0.0001. Decreased PhK activity in curcumin-and calcipotriol-treated psoriasis was associated with corresponding decreases in keratinocyte transferrin receptor (TRR) expression, severity of parakeratosis and density of epidermal CD8+ T cells. Our results demonstrate that drug-induced suppression of PhK activity is associated with resolution of psoriatic activity as assessed by clinical, histological and immunohistochemical criteria, and support the hypothesis that effective antipsoriatic activity may be achieved through modulation of PhK activity.
Article
To assess the efficacy and safety of external application of Chinese herbal drugs (ex-CHD) in the treatment of psoriasis. Literature regarding randomized clinical trials (RCTs) of psoriasis treatments with ex-CHD, either alone or combined with Western medicine (WM) or physiotherapy, controlled by untreated, placebo or WM treatment were found in electronic databases, including PubMed/MEDLINE, EMBASE, Cochrane Library, Cochrane Central Register of Controlled Trials, China Biology Medicine Disc (CBM), Chinese National Knowledge Infrastructure (CNKI), Wanfang database and VIP database from their inception through July 2011. Study selection, data extraction, quality assessment, and data analyses were conducted according to the Cochrane standards. A total of 10 randomized trials (involving 1,435 patients) were included. Because both test and control drugs used in the RCTs were different from each other, the effects can only be described singly and calculated. Regarding the total effective rate for the treatment of psoriasis, ex-CHD in combination with ultraviolet radiation b (UVB) or narrow band ultraviolet radiation b (NB-UVB), which was reported in 6 trials, was superior to UVB alone. One study reported that ex-CHD and externally applied WM had equivalent effects. In another study, ex-CHD showed better results than placebo. However, another two comparisons of ex-CHD and WM (all in combining with oral WM) showed uncertain outcomes. Nine trials reported adverse reactions. Of these, 7 RCTs included statistical analysis. The results showed that the side-effects that occurred in ex-CHD combined with UVB were less severe than those caused by UVB alone, but the incidence was roughly the same as WM. The evidence supporting the efficacy of ex-CHD with respect to treating psoriasis is quite limited and must be strengthened by high-quality studies.